These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 25884234)

  • 21. Glycosyl coumarin carbonic anhydrase IX and XII inhibitors strongly attenuate the growth of primary breast tumors.
    Touisni N; Maresca A; McDonald PC; Lou Y; Scozzafava A; Dedhar S; Winum JY; Supuran CT
    J Med Chem; 2011 Dec; 54(24):8271-7. PubMed ID: 22077347
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Carbonic anhydrase IX inhibitors in cancer therapy: an update.
    Supuran CT; Winum JY
    Future Med Chem; 2015; 7(11):1407-14. PubMed ID: 26230880
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Targeting carbonic anhydrase IX by nitroimidazole based sulfamides enhances the therapeutic effect of tumor irradiation: a new concept of dual targeting drugs.
    Dubois L; Peeters SG; van Kuijk SJ; Yaromina A; Lieuwes NG; Saraya R; Biemans R; Rami M; Parvathaneni NK; Vullo D; Vooijs M; Supuran CT; Winum JY; Lambin P
    Radiother Oncol; 2013 Sep; 108(3):523-8. PubMed ID: 23849171
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Selective carbonic anhydrase IX inhibitors based on coumarin scaffold as promising antimetastatic agents: WO2012070024.
    Carradori S
    Expert Opin Ther Pat; 2013; 23(6):751-6. PubMed ID: 23387899
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Carbonic anhydrase IX: a new druggable target for the design of antitumor agents.
    Winum JY; Rami M; Scozzafava A; Montero JL; Supuran C
    Med Res Rev; 2008 May; 28(3):445-63. PubMed ID: 17880011
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Quantitative assessment of specific carbonic anhydrase inhibitors effect on hypoxic cells using electrical impedance assays.
    Stanica L; Gheorghiu M; Stan M; Polonschii C; David S; Bratu D; Dinischiotu A; Supuran CT; Gheorghiu E
    J Enzyme Inhib Med Chem; 2017 Dec; 32(1):1079-1090. PubMed ID: 28783982
    [TBL] [Abstract][Full Text] [Related]  

  • 27. 6-Substituted sulfocoumarins are selective carbonic anhdydrase IX and XII inhibitors with significant cytotoxicity against colorectal cancer cells.
    Grandane A; Tanc M; Di Cesare Mannelli L; Carta F; Ghelardini C; Žalubovskis R; Supuran CT
    J Med Chem; 2015 May; 58(9):3975-83. PubMed ID: 25875209
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Progress in the study of carbonic anhydrase inhibitors as potential anticancer drugs].
    Guo J; Li FR; Liu Y; Cheng MS
    Yao Xue Xue Bao; 2013 Nov; 48(11):1637-43. PubMed ID: 24475699
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Development of carbonic anhydrase IX-targeting molecular-targeted photodynamic therapy.
    Miura K; Nakamura H
    Bioorg Med Chem Lett; 2024 Sep; 109():129821. PubMed ID: 38810709
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Targeting tumor-associated carbonic anhydrase IX in cancer therapy.
    Thiry A; Dogné JM; Masereel B; Supuran CT
    Trends Pharmacol Sci; 2006 Nov; 27(11):566-73. PubMed ID: 16996620
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Depletion of carbonic anhydrase IX abrogates hypoxia-induced overexpression of stanniocalcin-1 in triple negative breast cancer cells.
    Zandberga E; Zayakin P; Ābols A; Pūpola D; Trapencieris P; Linē A
    Cancer Biol Ther; 2017 Aug; 18(8):596-605. PubMed ID: 28665755
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lansoprazole and carbonic anhydrase IX inhibitors sinergize against human melanoma cells.
    Federici C; Lugini L; Marino ML; Carta F; Iessi E; Azzarito T; Supuran CT; Fais S
    J Enzyme Inhib Med Chem; 2016; 31(sup1):119-125. PubMed ID: 27142956
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Carbonic anhydrase IX is an independent predictor of survival in advanced renal clear cell carcinoma: implications for prognosis and therapy.
    Bui MH; Seligson D; Han KR; Pantuck AJ; Dorey FJ; Huang Y; Horvath S; Leibovich BC; Chopra S; Liao SY; Stanbridge E; Lerman MI; Palotie A; Figlin RA; Belldegrun AS
    Clin Cancer Res; 2003 Feb; 9(2):802-11. PubMed ID: 12576453
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sulfonamides incorporating boroxazolidone moieties are potent inhibitors of the transmembrane, tumor-associated carbonic anhydrase isoforms IX and XII.
    Rami M; Maresca A; Smaine FZ; Montero JL; Scozzafava A; Winum JY; Supuran CT
    Bioorg Med Chem Lett; 2011 May; 21(10):2975-9. PubMed ID: 21470859
    [TBL] [Abstract][Full Text] [Related]  

  • 35. High-Affinity NIR-Fluorescent Inhibitors for Tumor Imaging via Carbonic Anhydrase IX.
    Žvinys G; Petrosiute A; Zakšauskas A; Zubrienė A; Ščerbavičienė A; Kalnina Z; Čapkauskaitė E; Juozapaitienė V; Mickevičiu Tė A; Shubin K; Grincevičienė Š; Raišys S; Tars K; Matulienė J; Matulis D
    Bioconjug Chem; 2024 Jun; 35(6):790-803. PubMed ID: 38750635
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A Carbonic Anhydrase IX (CAIX)-Anchored Rhenium(I) Photosensitizer Evokes Pyroptosis for Enhanced Anti-Tumor Immunity.
    Su X; Wang WJ; Cao Q; Zhang H; Liu B; Ling Y; Zhou X; Mao ZW
    Angew Chem Int Ed Engl; 2022 Feb; 61(8):e202115800. PubMed ID: 34842317
    [TBL] [Abstract][Full Text] [Related]  

  • 37. New approach of delivering cytotoxic drugs towards CAIX expressing cells: A concept of dual-target drugs.
    van Kuijk SJA; Parvathaneni NK; Niemans R; van Gisbergen MW; Carta F; Vullo D; Pastorekova S; Yaromina A; Supuran CT; Dubois LJ; Winum JY; Lambin P
    Eur J Med Chem; 2017 Feb; 127():691-702. PubMed ID: 27823879
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The carbonic anhydrase IX inhibitor SLC-0111 sensitises cancer cells to conventional chemotherapy.
    Andreucci E; Ruzzolini J; Peppicelli S; Bianchini F; Laurenzana A; Carta F; Supuran CT; Calorini L
    J Enzyme Inhib Med Chem; 2019 Dec; 34(1):117-123. PubMed ID: 30362384
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Design and synthesis of novel 4-(4-oxo-2-arylthiazolidin-3-yl)benzenesulfonamides as selective inhibitors of carbonic anhydrase IX over I and II with potential anticancer activity.
    Suthar SK; Bansal S; Lohan S; Modak V; Chaudhary A; Tiwari A
    Eur J Med Chem; 2013 Aug; 66():372-9. PubMed ID: 23827177
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Carbonic anhydrase inhibitors: novel sulfonamides incorporating 1,3,5-triazine moieties as inhibitors of the cytosolic and tumour-associated carbonic anhydrase isozymes I, II and IX.
    Garaj V; Puccetti L; Fasolis G; Winum JY; Montero JL; Scozzafava A; Vullo D; Innocenti A; Supuran CT
    Bioorg Med Chem Lett; 2005 Jun; 15(12):3102-8. PubMed ID: 15905091
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.